The regulatory file for fish protein peptides
Fish protein peptides are a fish-derived ingredient, so the regulatory file has to answer two questions at once: whether the hydrolysate has a route in the destination, and how the fish allergen is declared. The buyer's regulatory team confirms the route for the finished product, the dose and the market. The supplier's file supplies the source, specification, lot data and allergen statement that the review depends on.
The specification defines the powder; the market file defines the route, the fish allergen declaration and the label.
What the file has to answer
A complete file has four jobs. It identifies the material and the specification revision; it ties the release to a lot and a certificate; it sets out the route, the limits and the label for the destination; and it records what happens when the source, process or pack changes. The certificate covers the lot, the technical data sheet covers the specification and the safety data sheet covers handling. The route is a separate question, answered by the buyer's regulatory team.
Two documents matter more here than in a generic protein file. One is the allergen statement, naming fish in the form the destination requires. The other is the source record, with the species or mix, the tissue and the origin. A certificate that names no species cannot support a species claim on the label.
European Union
Novel food is the first EU question. Regulation (EU) 2015/2283 covers food that was not used for human consumption to a significant degree in the Union before 15 May 1997. Whether a given fish protein hydrolysate falls inside that definition turns on its history, so the buyer's team checks the novel food catalogue and the evidence for this exact material. This page asserts no status.
The remaining references are Regulation (EU) No 1169/2011 (food information), Regulation (EC) No 1924/2006 (claims) and Commission Regulation (EU) 2023/915 (contaminants). Fish is in Annex II of the food-information regulation; the entry exempts certain fish gelatin uses as a processing aid, not a fish protein ingredient. Great Britain keeps its own register and labelling rules; Northern Ireland follows the EU list. Check the consolidated text, because these instruments are amended.
United States
The US review begins with the intended use and the basis on which the ingredient is sold. For a supplement, the ingredient is assessed under the Federal Food, Drug, and Cosmetic Act, as amended by DSHEA. A new dietary ingredient needs a 21 CFR 190.6 notification at least 75 days before marketing; the buyer's team decides whether that route applies.
cGMP sits in 21 CFR 111 and labelling in 21 CFR 101. FALCPA lists fish as a major food allergen, and the declaration should name the fish species where the label makes that claim. A structure/function claim still needs substantiation, with a notification within 30 days of marketing under 21 CFR 101.93; a disease claim cannot be made for a supplement. The claims review stands apart from the lot certificate.
Contaminants, allergens and the finished dose
| Parameter | Catalog limit | Question for the file |
|---|---|---|
| Lead (Pb) | ≤3 mg/kg | Lot result, method and finished-product calculation |
| Arsenic (As) | ≤2 mg/kg | Total arsenic; whether the market requires speciation |
| Cadmium (Cd) | ≤1 mg/kg | Lot result and any category exception |
| Mercury (Hg) | ≤0.1 mg/kg | Lot result and method |
| Histamine | Not on the catalog panel | Risk-based test for susceptible species and cold-chain control |
| Microbiology | APC, yeast and mould, absence tests | Count and absence statement for the lot |
| Fish allergen | Declared | Statement on the specification and the label, with the species |
Contaminant limits are calculated on the finished product, not on the drum. The destination text and the daily dose set the limit, and a result that passes at 1 g/day may fail at 10 g/day. Arsenic and mercury deserve particular attention in a marine source, and histamine is the fish-specific hazard that a generic protein file does not cover. Ask whether the source monitors it and whether the lot can meet the destination criterion.
Claims and the label
No disease-related claim is made for this ingredient. In the EU, a health claim must appear in the authorised list, and a protein nutrition claim is worked out on the finished product, not the raw powder. “Peptide” describes a fraction; it is not an authorised claim, and the number behind it belongs in the specification if the label uses the word.
In the US, the Supplement Facts panel names the ingredient, and a structure/function claim needs substantiation. “Fish-free” is not available for this product, and “hypoallergenic” is not supported by the file. The fish declaration is mandatory, not a marketing choice. The brand's reviewer owns the wording; the certificate cannot approve it.
Documents to keep on file
- Specification with the revision number, the species or species mix, the tissue, the nitrogen factor and the peptide window.
- Certificate of analysis for the lot, with methods, limits and measured results.
- Technical data sheet and safety data sheet.
- Fish allergen statement, with the species named where the market expects it.
- Origin record and, where a species claim is made, the supporting traceability or species test.
- Heavy-metal, microbiology and histamine results where the destination or the customer requires them.
- Nutritional data and the evidence for any claim the brand plans.
Before the first order
- The specification revision names the species or mix and the tissue.
- The buyer's regulatory team has confirmed the route for the destination.
- The fish allergen statement is on file and matches the lot and the label.
- Contaminant results have been recalculated at the finished-product dose.
- Label, nutrition panel and claim wording have had a market review.
- Change control names the source, the process and the pack, and the quotation, specification and certificate cite one version.
Start with the fish protein peptides page for the catalog; the COA page explains the lot certificate; the identity page covers the source evidence; the methods library holds the assay notes; the release file is described on the quality page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation